Callahan P M, Appel J B
Department of Psychology, University of South Carolina, Columbia.
J Pharmacol Exp Ther. 1988 Sep;246(3):866-70.
The stimulus properties of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA) and several related compounds were compared to those of (+)-lysergic acid diethylamide (LSD) and mescaline (3,4,5-trimethoxyphenylethylamine) in a two-lever, water-reinforced, drug discrimination task. In animals trained to discriminate LSD (0.08 mg/kg) from saline (n = 8), LSD-like responding occurred during substitution (generalization) tests with sufficiently high doses of (+/- )-2,5-dimethoxy-4-methylamphetamine, LSD, mescaline, psilocybin and (-)-MDA; saline appropriate responding occurred after (+)-MDA and both (+)- and (+)- and (-)-MDMA. In animals trained to discriminate mescaline (10 mg/kg; n = 8), (-)-MDA, (+)-MDA, (-)-MDMA and (+)-MDMA as well as (+/- )-2,5-dimethoxy-4-methylamphetamine, LSD, mescaline and psilocybin mimicked the training drug. Neither (+)-amphetamine nor cocaine produced mescaline-like responding; fenfluramine substituted partially for mescaline but not LSD. Because all of the phenylisopropylamine enantiomers mimicked the potent hallucinogen mescaline (10 mg/kg), these results do not support suggestions that similarities in the behavioral effects of "designer" drugs such as MDA and MDMA to those of hallucinogens are limited to (-)-MDA. They also indicate that, although LSD and mescaline may be pharmacologically similar (in other assays), these compounds do not have identical stimulus properties.
在一项双杠杆、水强化的药物辨别任务中,比较了3,4-亚甲基二氧基苯丙胺(MDA)、3,4-亚甲基二氧基甲基苯丙胺(MDMA)及几种相关化合物与(+)-麦角酸二乙酰胺(LSD)和三甲氧苯乙胺(3,4,5-三甲氧基苯乙胺)的刺激特性。在训练动物辨别LSD(0.08 mg/kg)和生理盐水(n = 8)的实验中,用足够高剂量的(±)-2,5-二甲氧基-4-甲基苯丙胺、LSD、三甲氧苯乙胺、裸盖菇素和(-)-MDA进行替代(泛化)测试时,出现了类似LSD的反应;给予(+)-MDA以及(+)-和(-)-MDMA后,出现了对生理盐水的适当反应。在训练动物辨别三甲氧苯乙胺(10 mg/kg;n = 8)的实验中,(-)-MDA、(+)-MDA、(-)-MDMA和(+)-MDMA以及(±)-2,5-二甲氧基-4-甲基苯丙胺、LSD、三甲氧苯乙胺和裸盖菇素都能模拟训练药物。(+)-苯丙胺和可卡因都未产生类似三甲氧苯乙胺的反应;芬氟拉明部分替代了三甲氧苯乙胺,但不能替代LSD。由于所有苯异丙胺对映体都能模拟强效致幻剂三甲氧苯乙胺(10 mg/kg),这些结果不支持以下观点,即MDA和MDMA等“设计药物”与致幻剂行为效应的相似性仅限于(-)-MDA。它们还表明,尽管LSD和三甲氧苯乙胺在药理学上可能相似(在其他测定中),但这些化合物的刺激特性并不相同。